Tabulation of myeloid, lymphoid and intestinal malignancies in Crohn's disease

被引:16
作者
Freeman, HJ [1 ]
机构
[1] Univ British Columbia, Dept Med Gastroenterol, Vancouver, BC V5Z 1M9, Canada
来源
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2002年 / 16卷 / 11期
关键词
colon cancer; Crohn's disease; immunosuppressives; infliximab; leukemia; multiple myeloma; small intestinal cancer;
D O I
10.1155/2002/193285
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A variety of malignant complications occur in Crohn's disease, and previous studies have recorded an increased intestinal cancer risk. The present investigation tabulated myeloid and lymphoid malignancies compared with intestinal cancers in 1000 consecutively evaluated patients with Crohn's disease who were followed over an extended period by a single clinician. Myeloid and lymphoid neoplasms were present in 0.5% of patients, while cancer in the intestinal tract was detected in 1%. Most of these patients with a malignancy had Crohn's disease for a prolonged period of more than 20 years and had negative outcomes, including death or presentations with advanced disease. In this cohort, lymphoma was not detected in a single patient after definition of Crohn's disease, possibly reflecting the limited use of immunosuppressives or infused biological agents in this clinical practice. Bypassed rectal 'stumps' were associated with subsequent colorectal cancer in half of all males with colon cancer in this series, suggesting an important risk factor following colectomy in Crohn's disease. Epithelial dysplasia was detected in only a single male patient before colorectal cancer, implying that this histopathological marker may be a poor predictor of subsequent colon cancer development in Crohn's disease, an inflammatory bowel disease process that is typically patchy or focal in distribution in the intestinal tract.
引用
收藏
页码:779 / 784
页数:6
相关论文
共 40 条
[1]  
Asten P, 1999, J RHEUMATOL, V26, P1705
[2]  
Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO
[3]  
2-Z
[4]   The relationship between infliximab treatment and lymphoma in Crohn's disease [J].
Bickston, SJ ;
Lichtenstein, GR ;
Arseneau, KO ;
Cohen, RB ;
Cominelli, F .
GASTROENTEROLOGY, 1999, 117 (06) :1433-1437
[5]   Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine [J].
Dayharsh, GA ;
Loftus, EV ;
Sandborn, WJ ;
Tremaine, WJ ;
Zinsmeister, AR ;
Witzig, TE ;
Macon, WR ;
Burgart, LJ .
GASTROENTEROLOGY, 2002, 122 (01) :72-77
[6]   Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low [J].
Farrell, RJ ;
Ang, Y ;
Kileen, P ;
O'Briain, DS ;
Kelleher, D ;
Keeling, PWN ;
Weir, DG .
GUT, 2000, 47 (04) :514-519
[7]   Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease [J].
Fedorak, RN ;
Gangl, A ;
Elson, CO ;
Rutgeerts, P ;
Schreiber, S ;
Wild, G ;
Hanauer, SB ;
Kilian, A ;
Cohard, M ;
LeBeaut, A ;
Feagan, B .
GASTROENTEROLOGY, 2000, 119 (06) :1473-1482
[8]   Neoplastic disorders in 100 patients with adult celiac disease [J].
Freeman, HJ .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 1996, 10 (03) :163-166
[9]   PRIMARY ABDOMINAL LYMPHOMA - PRESENTING MANIFESTATION OF CELIAC SPRUE OR COMPLICATING DERMATITIS-HERPETIFORMIS [J].
FREEMAN, HJ ;
WEINSTEIN, WM ;
SHNITKA, TK ;
PIERCEY, JRA ;
WENSEL, RH .
AMERICAN JOURNAL OF MEDICINE, 1977, 63 (04) :585-594
[10]   MULTIFOCAL SMALL-BOWEL LYMPHOMA AND LATENT CELIAC SPRUE [J].
FREEMAN, HJ ;
CHIU, BK .
GASTROENTEROLOGY, 1986, 90 (06) :1992-1997